Clinical Trials

How to Participate in Psychedelic Clinical Trials

2026-06-08 · 8 min read

Reader note - official guidance checked September 1, 2026: PsychoactiveMap helps people discover mapped study records. It does not enroll participants, decide eligibility, recommend a study, or provide medical care. ClinicalTrials.gov is also a searchable registry rather than an enrollment service. Only the study team can explain whether a specific study is open and whether you may be eligible.

Begin with the right expectation

A clinical trial is research designed to answer a specific question. It is not a promise of treatment or personal benefit. Depending on the protocol, a participant may receive an investigational intervention, a comparator, a placebo, or no direct medical benefit. Participation can also require more visits, tests, forms, travel, or time than ordinary care.

A record on ClinicalTrials.gov does not mean that the U.S. government has evaluated or approved the study's safety or scientific validity. The sponsor or investigator is responsible for the submitted record, and the record may change. Before considering participation, review the current official record and discuss possible risks and benefits with your health care professional.

1. Find a study that may be looking for participants

Use the PsychoactiveMap research map to explore records by location, compound, and study status. A Join link on a mapped record is a shortcut to the official ClinicalTrials.gov Contacts and Locations section. It is not an application and it does not reserve a place.

ClinicalTrials.gov advises people looking for studies to use its Recruiting and not yet recruiting studies filter. The distinctions matter:

Recruiting means the study is currently recruiting participants.
Not yet recruiting means recruitment has not started, so contact information may not appear yet.
Enrolling by invitation means the study selects participants from a predetermined population rather than accepting general inquiries.
Active, not recruiting means the study is ongoing but is no longer adding participants.

Status information can become outdated. On the official record, check the recruitment status, the Last Update Posted date, the locations, and whether a central or site-specific contact is shown.

2. Read the participation criteria and location details

Every trial has inclusion and exclusion criteria. These may cover age, the type or stage of a condition, treatment history, other medical conditions, medications, and study-specific requirements. The criteria help protect participants and make the research data interpretable, but a reader cannot confirm eligibility from a webpage alone.

Check whether a workable study location is listed and whether visits are in person, remote, or a mixture. Meeting the visible criteria does not guarantee enrollment; screening and the final decision belong to the study team.

If a criterion mentions a prescription or other treatment, do not stop, taper, or change it just to match the record. Discuss it with the prescribing clinician and the study team.

3. Contact the study team directly

ClinicalTrials.gov cannot sign you up or match you to a study. For a record that is accepting inquiries, use the phone number or email in Contacts and Locations to reach the central contact or a contact at a specific site.

Ask whether that location is still recruiting and what the screening process involves. If no contact appears, the study may not be actively recruiting at that time. If a listed contact does not respond, the registry notes that the information may be stale; try another listed site, look for a similar study, or ask your health care professional about other options.

Do not send sensitive medical details to an address unless the study team has told you how it handles them securely.

4. Treat informed consent as a process, not a signature

Before joining, the study team should explain the study in understandable language and give you an opportunity to ask questions. Informed consent should cover the purpose, duration, visits, procedures, possible risks and benefits, alternatives, privacy, and how data will be used. Signing a consent form does not waive the need for an ongoing conversation.

Participation is voluntary. Federal participant guidance says that you may stop participating at any time. Ask in advance what withdrawal would mean for scheduled follow-up and for information already collected.

For U.S. studies, ask which Institutional Review Board reviewed the protocol and whom to contact about participant rights or a research-related concern. Protections and oversight structures outside the United States may differ, so ask the local study team to identify the applicable ethics review and participant-protection process.

5. Understand the design before deciding

The official record may describe randomization, masking, arms, a placebo, or a comparison treatment. These details determine what a participant may receive. You may not be able to choose an arm, and not every participant receives the investigational intervention.

For drug trials, ClinicalTrials.gov uses these phase definitions:

Phase 1 focuses primarily on safety, adverse events, and how a drug is handled by the body, usually in a small group.
Phase 2 gathers preliminary evidence about whether a drug works for a condition while continuing safety evaluation.
Phase 3 gathers more safety and effectiveness information across more participants, populations, doses, or combinations.
Phase 4 occurs after a drug has been approved for marketing and gathers additional information.

Some records, including behavioral or device studies, use Not Applicable rather than a drug phase. A phase label describes the research stage; it does not guarantee eligibility, benefit, approval, or safety.

6. Ask about time, costs, payment, and travel

ClinicalTrials.gov states that its records do not provide the costs or payments associated with a study. Ask the study contact:

Which visits, tests, interventions, or routine-care costs are paid by the study?
Could you or your insurer be billed for anything?
Are travel, lodging, meals, parking, or child care reimbursed?
Is compensation offered for time, and when is it paid?
Who pays for medical care if a research-related injury occurs?
How many visits and follow-up contacts are required, and over what period?

Do not assume that participation is free or paid. The answer is study-specific and should be explained before consent.

A practical verification checklist

Before sharing health information or agreeing to screen, confirm:

The official ClinicalTrials.gov identifier and current recruitment status.
The record's Last Update Posted date and a workable study location.
The participation criteria and the name of the study contact.
The study purpose, procedures, duration, randomization, masking, and any placebo or comparator.
The known risks, possible benefits, alternatives, and available safety contacts.
The consent, privacy, withdrawal, costs, payment, travel, and injury-care terms.
Whether your own health care professional has relevant concerns about participation.

Frequently asked questions

Can I enroll through PsychoactiveMap or ClinicalTrials.gov?

No. PsychoactiveMap is a discovery interface and ClinicalTrials.gov is a registry. Contact the study team listed on the official record.

Does a Recruiting label mean I will qualify?

No. It means the study reports that it is recruiting. The study team must confirm that the location is open and determine eligibility through screening.

Will I definitely receive the psychedelic intervention?

Not necessarily. The design may use randomization, a placebo, a comparator, or more than one study arm. Read the official design and ask the study team.

Is participation free, and will I be paid?

Do not assume either. ClinicalTrials.gov does not list study costs or payments. Ask about research costs, routine-care costs, insurance, compensation, and travel reimbursement.

Can I stop after I join?

Participation is voluntary and consent is ongoing. You may stop participating, but ask how withdrawal affects follow-up and data already collected.

Does a ClinicalTrials.gov listing mean the intervention is approved?

No. A registry listing is not an approval or an endorsement of safety or effectiveness. Verify the study design and discuss it with the study team and your clinician.

Primary official sources

This guide is educational and is not medical advice, an enrollment service, or an endorsement of any study. Verify every detail with the official study team and a qualified health care professional.